What question did this study set out to answer?

To study the prevalence, types, and characteristics of eye involvement in systemic sclerosis patients in Syria.

Ocular presentations in systemic scleroderma in a sample of Syrian patients: a cross-sectional study

View Full Paper

Ask AI

Bookmark

Authors

Cross-sectional study identifies ocular symptoms in systemic sclerosis patients, highlighting the need for routine screenings.

To study the prevalence, types, and characteristics of eye involvement in systemic sclerosis patients in Syria.
Cross-sectional design collecting demographic and clinical data from 106 scleroderma patients.
Conducted comprehensive ocular evaluations including visual acuity, slit-lamp, and fundus examinations.
Analyzed autoantibody profiles and treatment history among participants.
64.15% of patients reported ocular symptoms, with 11.76% experiencing pain and 23.5% reporting decreased vision.
75 patients (83.82%) had best-corrected visual acuity of 20/30 or better; 6 patients had BCVAs of 20/80 or worse due to cataracts.
No statistical differences were found in vision impairment related to age, disease duration, or treatment type.

Kudsi et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Cross-sectional study identifies ocular symptoms in systemic sclerosis patients, highlighting the need for routine screenings.

To study the prevalence, types, and characteristics of eye involvement in systemic sclerosis patients in Syria.
Cross-sectional design collecting demographic and clinical data from 106 scleroderma patients.
Conducted comprehensive ocular evaluations including visual acuity, slit-lamp, and fundus examinations.
Analyzed autoantibody profiles and treatment history among participants.
64.15% of patients reported ocular symptoms, with 11.76% experiencing pain and 23.5% reporting decreased vision.
75 patients (83.82%) had best-corrected visual acuity of 20/30 or better; 6 patients had BCVAs of 20/80 or worse due to cataracts.
No statistical differences were found in vision impairment related to age, disease duration, or treatment type.

Kudsi et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark